Trial Profile
A Clinical Study of Immune Globulin Intravenous (Human) Omr-IgG-am IGIV in Subjects With Primary Immune Deficiency Diseases
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 02 Oct 2014
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary)
- Indications Immunodeficiency disorders
- Focus Therapeutic Use
- Sponsors FFF Enterprises
- 19 May 2014 New trial record